Taro Pharmaceutical Industries Probability of Future Stock Price Finishing Under 42.03
TARODelisted Stock | USD 42.97 0.00 0.00% |
Taro |
Taro Pharmaceutical Target Price Odds to finish below 42.03
The tendency of Taro Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to drop to $ 42.03 or more in 90 days |
42.97 | 90 days | 42.03 | about 6.41 |
Based on a normal probability distribution, the odds of Taro Pharmaceutical to drop to $ 42.03 or more in 90 days from now is about 6.41 (This Taro Pharmaceutical Industries probability density function shows the probability of Taro Stock to fall within a particular range of prices over 90 days) . Probability of Taro Pharmaceutical price to stay between $ 42.03 and its current price of $42.97 at the end of the 90-day period is about 90.8 .
Given the investment horizon of 90 days Taro Pharmaceutical Industries has a beta of -0.0496. This usually implies as returns on the benchmark increase, returns on holding Taro Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, Taro Pharmaceutical Industries is likely to outperform the market. Additionally Taro Pharmaceutical Industries has an alpha of 0.0266, implying that it can generate a 0.0266 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Taro Pharmaceutical Price Density |
Price |
Predictive Modules for Taro Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Taro Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Taro Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Taro Pharmaceutical is not an exception. The market had few large corrections towards the Taro Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Taro Pharmaceutical Industries, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Taro Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | -0.05 | |
σ | Overall volatility | 0.27 | |
Ir | Information ratio | -0.37 |
Taro Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Taro Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Taro Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Taro Pharmaceutical is not yet fully synchronised with the market data | |
Taro Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
About 78.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from businesswire.com: Morgan Stanley Capital Partners Acquires FoodScience |
Taro Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Taro Stock often depends not only on the future outlook of the current and potential Taro Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Taro Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 37.6 M | |
Cash And Short Term Investments | 879.4 M |
Taro Pharmaceutical Technical Analysis
Taro Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Taro Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Taro Pharmaceutical Industries. In general, you should focus on analyzing Taro Stock price patterns and their correlations with different microeconomic environments and drivers.
Taro Pharmaceutical Predictive Forecast Models
Taro Pharmaceutical's time-series forecasting models is one of many Taro Pharmaceutical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Taro Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Taro Pharmaceutical
Checking the ongoing alerts about Taro Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Taro Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Taro Pharmaceutical is not yet fully synchronised with the market data | |
Taro Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
About 78.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from businesswire.com: Morgan Stanley Capital Partners Acquires FoodScience |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Taro Stock
If you are still planning to invest in Taro Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taro Pharmaceutical's history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |